Data / Drug companies / Loop Diuretic
Loop Diuretic drugs: 6 drugs from 102 companies in the FDA NDC directory
Loop Diuretic is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 423 products in this class from 102 companies, covering 6 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on September 28, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 102Companies
- 423Products
- 6Drugs by generic name
Drugs in the Loop Diuretic class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Furosemide | 220 | 63 |
| Bumetanide | 127 | 42 |
| Torsemide | 63 | 25 |
| Ethacrynic acid | 10 | 10 |
| Ethacrynate sodium | 2 | 2 |
| Furosemide injection 80 mg/ 10 ml | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 34 | tablet | Generic drugs (ANDA) | April 3, 2025 |
| Bryant Ranch Prepack | 14 | tablet | Generic drugs (ANDA) | July 24, 2023 |
| Remedyrepack Inc. | 13 | tablet; injection, solution | Generic drugs (ANDA) | June 22, 2026 |
| Cardinal Health 107, LLC | 11 | injection, solution; tablet | Generic drugs (ANDA) | July 1, 2026 |
| Bryant Ranch Prepack | 10 | tablet; injection | Generic drugs (ANDA) | July 24, 2023 |
| Camber Pharmaceuticals, Inc. | 9 | tablet; injection, solution | Generic drugs (ANDA) | February 27, 2025 |
| HF Acquisition Co LLC, DBA HealthFirst | 9 | injection, solution; injection | New drug applications (NDA) | December 13, 2024 |
| Hikma Pharmaceuticals USA Inc. | 9 | tablet; solution | Generic drugs (ANDA) | March 3, 2005 |
| Medical Purchasing Solutions, LLC | 9 | injection, solution; injection | Generic drugs (ANDA) | August 19, 2024 |
| NorthStar RxLLC | 9 | tablet; injection, solution | Generic drugs (ANDA) | June 1, 2026 |
| NuCare Pharmaceuticals,Inc. | 9 | tablet | Generic drugs (ANDA) | November 5, 2022 |
| Aphena Pharma Solutions - Tennessee, LLC | 8 | tablet | Generic drugs (ANDA) | January 4, 2022 |
| Bryant Ranch Prepack | 8 | tablet | Generic drugs (ANDA) | July 30, 2020 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 8 | tablet; injection, solution | Generic drugs (ANDA) | July 15, 2025 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 8 | tablet | Generic drugs (ANDA) | January 16, 2025 |
| AvKARE | 7 | tablet | Generic drugs (ANDA) | January 4, 2022 |
| AvPAK | 7 | tablet | Generic drugs (ANDA) | April 23, 2019 |
| Baxter Healthcare Corporation | 6 | injection, solution | Generic drugs (ANDA) | February 6, 2014 |
| Chartwell RX, LLC | 6 | tablet | Generic drugs (ANDA) | May 31, 2005 |
| Civica, Inc. | 6 | injection, solution; injection | Generic drugs (ANDA) | August 1, 2026 |
| Lifestar Pharma LLC | 6 | tablet; injection, solution | Generic drugs (ANDA) | April 3, 2025 |
| Solco Healthcare US, LLC | 6 | tablet | Generic drugs (ANDA) | March 1, 2025 |
| Validus Pharmaceuticals LLC | 6 | tablet | New drug applications (NDA) | February 28, 1983 |
| Gland Pharma Limited | 5 | injection, solution; injection | Generic drugs (ANDA) | May 26, 2022 |
| Hikma Pharmaceuticals USA Inc. | 5 | injection | New drug applications (NDA) | August 19, 2024 |
| Novadoz Pharmaceuticals LLC | 5 | tablet; injection | Generic drugs (ANDA) | February 5, 2026 |
| Amneal Pharmaceuticals NY LLC | 4 | tablet | Generic drugs (ANDA) | May 14, 2018 |
| Aphena Pharma Solutions - Tennessee, LLC | 4 | tablet | Generic drugs (ANDA) | March 3, 2005 |
| Aurobindo Pharma Limited | 4 | tablet | Generic drugs (ANDA) | October 17, 2007 |
| Coupler LLC | 4 | tablet | Generic drugs (ANDA) | June 10, 2026 |
| Edenbridge Pharmaceuticals LLC. | 4 | tablet | Authorized generics (NDA) | July 1, 2016 |
| Golden State Medical Supply, Inc. | 4 | tablet | Generic drugs (ANDA) | May 31, 2005 |
| Hikma Pharmaceuticals USA Inc. | 4 | injection; injection, solution | Generic drugs (ANDA) | April 30, 2008 |
| Leading Pharma, LLC | 4 | tablet; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 9, 2026 |
| Major Pharmaceuticals | 4 | tablet | Generic drugs (ANDA) | October 18, 2017 |
| Northwind Health Company, LLC | 4 | tablet | Generic drugs (ANDA) | November 28, 2022 |
| PD-Rx Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | March 26, 2004 |
| Preferred Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | April 30, 2025 |
| Proficient Rx LP | 4 | tablet | Generic drugs (ANDA) | February 1, 2006 |
| Redpharm Drug | 4 | tablet | Generic drugs (ANDA) | November 5, 2022 |
| Rising Pharma Holdings, Inc. | 4 | tablet | Generic drugs (ANDA) | October 17, 2007 |
| Teva Pharmaceuticals USA, Inc. | 4 | tablet | Generic drugs (ANDA) | October 20, 2004 |
| XLCare Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | September 10, 2024 |
| Accord Healthcare Inc. | 3 | injection | Generic drugs (ANDA) | May 5, 2021 |
| Advagen Pharma Ltd | 3 | tablet | Generic drugs (ANDA) | January 16, 2025 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | July 17, 2025 |
| Devatis, Inc. | 3 | injection, solution | Generic drugs (ANDA) | August 10, 2024 |
| Eugia US LLC | 3 | injection, solution | Generic drugs (ANDA) | May 3, 2019 |
| Exelan Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | March 1, 2025 |
| First Nation Group, LLC | 3 | tablet | Generic drugs (ANDA) | February 19, 2026 |
| Granulation Technology, Inc. | 3 | tablet | New drug applications (NDA) | December 18, 2025 |
| Henry Schein, Inc. | 3 | injection, solution | Generic drugs (ANDA) | January 10, 2022 |
| Ipca Laboratories Limited | 3 | tablet | Generic drugs (ANDA) | June 3, 2024 |
| Maiva Pharma Private Limited | 3 | injection | Generic drugs (ANDA) | June 16, 2025 |
| Marlex Pharmaceuticals, Inc. | 3 | tablet | New drug applications (NDA) | March 1, 2026 |
| Micro Labs Limited | 3 | injection | Generic drugs (ANDA) | March 1, 2026 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | February 1, 2006 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | March 1, 2025 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Generic drugs (ANDA) | June 3, 2024 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Generic drugs (ANDA) | November 5, 2022 |
| Sagent Pharmaceuticals | 3 | injection, solution | Generic drugs (ANDA) | July 15, 2025 |
| Sandoz Inc | 3 | tablet | Generic drugs (ANDA) | September 28, 2026 |
| Sandoz Inc | 3 | tablet | Generic drugs (ANDA) | November 21, 1996 |
| Sun Pharmaceutical Industries, Inc. | 3 | tablet | Generic drugs (ANDA) | July 24, 2023 |
| Zydus Lifesciences Limited | 3 | tablet | Generic drugs (ANDA) | May 1, 2018 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet | Generic drugs (ANDA) | May 1, 2018 |
| American Health Packaging | 2 | tablet | Authorized generics (NDA) | July 13, 2020 |
| Amneal Pharmaceuticals LLC | 2 | injection | Generic drugs (ANDA) | July 25, 2016 |
| Anthea Pharma Private Limited | 2 | injection, solution | Generic drugs (ANDA) | February 27, 2026 |
| Atlantic Biologicals Corp. | 2 | solution | Generic drugs (ANDA) | July 12, 1988 |
| Calvin Scott & Co., Inc. | 2 | tablet | Generic drugs (ANDA) | February 1, 2006 |
| Direct RX | 2 | tablet | Generic drugs (ANDA) | October 21, 2021 |
| Fresenius Kabi USA, LLC | 2 | injection, solution | New drug applications (NDA) | July 12, 2000 |
| Fresenius Kabi USA, LLC | 2 | injection | Generic drugs (ANDA) | September 26, 2022 |
| Glenmark Pharmaceuticals Inc., USA | 2 | injection | Generic drugs (ANDA) | January 1, 2023 |
| Hospira, Inc. | 2 | injection, solution | New drug applications (NDA) | November 19, 2013 |
| Meitheal Pharmaceuticals Inc. | 2 | injection, solution | Generic drugs (ANDA) | January 27, 2022 |
| Mullan Pharmaceutical Inc. | 2 | injection | Generic drugs (ANDA) | January 9, 2026 |
| Precision Dose, Inc. | 2 | solution | Generic drugs (ANDA) | January 28, 2016 |
| ProPharma Distribution | 2 | injection, solution | Generic drugs (ANDA) | February 1, 2023 |
| Qilu Pharmaceutical Co., Ltd. | 2 | injection | Generic drugs (ANDA) | September 19, 2024 |
| St. Mary's Medical Park Pharmacy | 2 | tablet | Generic drugs (ANDA) | June 15, 2023 |
| scPharmaceuticals Inc., a Wholly Owned Subsidiary of MannKind Corporation | 2 | injection | New drug applications (NDA) | July 27, 2026 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | October 19, 2011 |
| Avenacy, LLC | 1 | injection, solution | Generic drugs (ANDA) | March 15, 2024 |
| Bausch Health US, LLC | 1 | tablet | New drug applications (NDA) | January 10, 1967 |
| Corstasis USA LLC | 1 | spray | New drug applications (NDA) | September 12, 2025 |
| Direct_Rx | 1 | tablet | Generic drugs (ANDA) | May 11, 2020 |
| Kesin Pharma Corporation | 1 | tablet | Generic drugs (ANDA) | January 1, 2011 |
| Lupin Pharmaceuticals, Inc. | 1 | injection | Generic drugs (ANDA) | November 11, 2024 |
| Lupin Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | February 24, 2020 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | February 29, 2024 |
| Oceanside Pharmaceuticals | 1 | tablet | Authorized generics (NDA) | January 10, 1967 |
| Par Health USA, LLC | 1 | injection, powder, for solution | Generic drugs (ANDA) | July 30, 2015 |
| Phlow Corporation | 1 | injection, solution | New drug applications (NDA) | February 1, 2022 |
| QPharma, Inc. | 1 | tablet | Generic drugs (ANDA) | February 1, 2006 |
| SQ Innovation, Inc. | 1 | injection | New drug applications (NDA) | December 1, 2025 |
| Sarfez Pharmaceuticals Inc | 1 | tablet, film coated | New drug applications (NDA) | January 24, 2022 |
| ScieGen Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | August 27, 2019 |
| TruPharma, LLC | 1 | tablet | Generic drugs (ANDA) | September 12, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 298 | 70.4% |
| Injection, solution | 69 | 16.3% |
| Injection | 46 | 10.9% |
| Solution | 6 | 1.4% |
| Injection, powder, for solution | 1 | 0.2% |
| Spray | 1 | 0.2% |
| Tablet, film coated | 1 | 0.2% |
| Injection, powder, lyophilized, for solution | 1 | 0.2% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.